EQNSX
Price
$23.78
Change
-$0.07 (-0.29%)
Updated
Oct 7 closing price
Net Assets
685.39M
RWMHX
Price
$67.22
Change
-$0.17 (-0.25%)
Updated
Oct 7 closing price
Net Assets
209.3B
Interact to see
Advertisement

EQNSX vs RWMHX

Header iconEQNSX vs RWMHX Comparison
Open Charts EQNSX vs RWMHXBanner chart's image
MFS Equity Income R2
Price$23.78
Change-$0.07 (-0.29%)
VolumeN/A
Net Assets685.39M
American Funds Washington Mutual R5E
Price$67.22
Change-$0.17 (-0.25%)
VolumeN/A
Net Assets209.3B
EQNSX vs RWMHX Comparison Chart in %
View a ticker or compare two or three
VS
EQNSX vs. RWMHX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EQNSX is a Buy and RWMHX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWMHX has more cash in the bank: 209B vs. EQNSX (685M). EQNSX pays higher dividends than RWMHX: EQNSX (1.67) vs RWMHX (1.33). EQNSX was incepted earlier than RWMHX: EQNSX (13 years) vs RWMHX (10 years). EQNSX (1.20) is less costly to investors than RWMHX (0.41). EQNSX is a more actively managed with annual turnover of: 45.00 vs. RWMHX (29.00). EQNSX has a lower initial minimum investment than RWMHX: EQNSX (0) vs RWMHX (250). EQNSX annual gain was more profitable for investors over the last year : 9.26 vs. RWMHX (6.94). EQNSX return over 5 years is better than : 61.33 vs. RWMHX (52.00).
EQNSXRWMHXEQNSX / RWMHX
Total Expense Ratio1.140.41278%
Annual Report Gross Expense Ratio1.200.41293%
Fund Existence13 years10 years-
Gain YTD14.79310.618139%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets685M209B0%
Annual Yield % from dividends1.671.33126%
Returns for 1 year9.266.94133%
Returns for 3 years48.1645.52106%
Returns for 5 years61.3352.00118%
Returns for 10 years114.79N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XFOR3.440.07
+2.08%
X4 Pharmaceuticals Inc
PERI9.63-0.15
-1.53%
Perion Network Ltd
ALB90.53-1.50
-1.63%
Albemarle Corp
UK0.95-0.05
-5.25%
Ucommune International Ltd
ADNT24.29-1.49
-5.78%
Adient plc